Boost Response by Delaying Second Dose -- Pfizer vaccine in elderly

  • COVID
  • Thread starter Tom.G
  • Start date
  • #1
Tom.G
Science Advisor
3,938
2,632
This applies to the Pfizer vaccine. Article dated May 13, 2021.

https://www.nature.com/articles/d41586-021-01299-y

Older people who waited 11–12 weeks for their second jab had higher peak antibody levels than did those who waited only 3 weeks. ...could boost antibody responses after the second inoculation more than threefold in those older than 80. (bold added)

Cheers,
Tom
 
  • Informative
  • Like
Likes atyy, BillTre, phinds and 1 other person

Answers and Replies

  • #2
Ygggdrasil
Science Advisor
Insights Author
Gold Member
3,366
3,697
The Pfizer vaccine has already been observed to be very effective in older individuals (the original Phase III trial observed a 100% vaccine efficiency for those >75 (though this was based on a fairly low # of people) and real world data from Israel indicated a 95% protection for those > age 70. So, delaying the second dose probably would not increase protection very much (hard to do much better than 95% protection) and could actually lead to more disease if the protection before the second dose in weeks 3-11 is not effective as the protection from getting a second dose at week 3.

However, this data could be useful in designing vaccines going forward. For example, future vaccines might be able to use a lower dose of vaccine (which would hopefully have lower side effects) with greater spacing to achieve similar levels of protection.
 

Related Threads on Boost Response by Delaying Second Dose -- Pfizer vaccine in elderly

Replies
12
Views
294
  • Last Post
Replies
3
Views
242
Replies
30
Views
3K
  • Last Post
Replies
3
Views
165
  • Last Post
Replies
6
Views
2K
  • Last Post
Replies
4
Views
3K
  • Last Post
Replies
11
Views
512
Replies
31
Views
3K
Replies
1
Views
310
Replies
2
Views
5K
Top